FDA Mandates Contraindication for Cetrain MRI Contrast Agents
FDA Mandates Contraindication for Cetrain MRI Contrast Agents Spangenberg Shibley & Liber LLP attorneys Peter J. Brodhead, William Hawal and Peter H. Weinberger are representing numerous Nephrogenic Systemic Fibrosis patients in their lawsuits against GE Healthcare and its drug Omniscan. Cleveland, OH (PRWEB) November 9, 2010 On September 9, 2010 the FDA announced its decision to require changes to the labeling of gadolinium-based contrast agents (GBCAs) for use with patients with impaired kidney function who undergo MRI procedures. These changes are intended to minimize the risk of
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Related Documents in PR Web
Categories
- Articles 312
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4